Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titletx.xpt (trial sets)
  • During CT definition/reviews will decide appropriate TXPARM and TXVAL; Treatment duration may be controlled;  For now, we just include good example values based on our experience
  • Assumption: The Trial Sets (TX) domain provides the list of distinct sets of subjects having different experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations as specified in the trial design.
  • Where is TK6 cell type?  is this test system (see below)
    • needs to be allowed to vary down to the well level / result level

A1:


A2:                                   

RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it)
TXSEQTXPARMCDTXPARMTXVAL

123MNvitTX

A1

(table 1, row 1, ST exposure with S9)



METACTMetabolic Activation  (should there be two parms? Presence, type)?+S9







METACTFLY/N presence of metabolic activation

123MNvitTXA1

TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)3

123MNvitTXA1

TRTDRTOLTreatment Duration Tolerance

123MNvitTXA1

TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)H

123MNvitTXA1

INTRVN

name of the intervention article

(Tobacco ProdA, Bleomycin or Cyclophosphamid A)

Tobacco ProdA

123MNvitTXA1

ITVTYPE

type of intervention article

choices of values:  product; negative control; positive control

Product

123MNvitTXA1

ITVCONCConcentration of intervention article0

123MNvitTXA1

ITVCONCUConcentration Unitug/ml

123MNvitTX

A2

(table 1, row 2)



METACTMetabolic Activation  (should there be two parms? Presence, type)?+S9

123MNvitTXA2

TRTDRTRGTreatment Duration target. (how do we show 3-6 hour range?  start/end, target and tolerance?, one text field not-analyzable)3

123MNvitTXA2

TRTDRTOLTreatment Duration Tolerance

123MNvitTXA2

TRTDURUTreatment Duration Unit (this is for both TRTDURT, TRTDURTOL)H

123MNvitTXA2

INTRVNname of the intervention articleTobacco ProdA

123MNvitTXA2

ITVTYPEtype of intervention articleProduct

123MNvitTXA2

ITVCONCConcentration of i a 1250

123MNvitTXA2

ITVCONCUConcentration Unitug/ml
...






































Expand
titleTC (Test Conditions) aka Smoking Regimen

The Test Conditions (TC) dataset allows for listing the attributes of the testing regimens used in tobacco product testing when the details are too long and variable for representing as a single value in the PTTSTCND variable in a PT dataset. 

The example below shows the attributes of the testing regimen identified as PTTSTCND="E-Liquid Standard Aerosol Condition" (see e-liquid stability study pt.xpt example). Note that the combination of TCVAR1="PTTSTCND" and TCVRVAL1="E-Liquid Standard (Long Term) Condition" identifies the specific testing regimen shown in PTTSTCND as the focus of the testing regimen parameters listed in TCPARMCD/TCPARM. TCVAL and TCVALU show the specific values and units (respectively, where applicable) for the given parameter.one testing regimen shown in the PT stability study above. 
(We've added TCVALU which was not originally part of the TC draft domain. May propose elevating this structure to a "Trial Lookup" observational class, within which some domains would allow for TCVALU) 

Dataset wrap
Nametc
Dataset2
RowSTUDYIDDOMAINRDOMAINTCVAR1TCVRVAL1TCSEQTCGRPIDTCPARMCDTCPARMTCVALTCVALU
1

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition1
PUFFPROFPuff ProfileSQUARE
2

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition2


PUFFDUR

Puff Duration

1.25

sec

3

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition3


PUFFINT

Puff Interval

3

PUFF/min

4

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition4


PUFFBLCK

Puff Block

25

%

5

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition5
NUMPUFFTotal Number of Puffs

200

PUFF

6

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition6
PUFFVOLPuff Volume

10

mL

7

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition7
PUFFRNGPuff Range

100-200


8

TOB07

TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition81PUFFPAUSPuff Pause

60

s

9TOB07TCPTPTTSTCNDE-Liquid Standard (Long Term) Condition91PUFFPINTPuff Pause Interval

10

PUFF

Expand
titlegt.xpt (similar to LB)

A1:


A2:                                   


RowSTUDYIDASSAYIDDOMAINTXSETCDGTSEQGTTESTCDGTTESTGTCELLEV
(cells evaluated)
GTORRESGTORRESUGTSTRESCGTSTRESNGTSTRESUGTDTC
1123MNvitGTA11RICCRelative Increase in Cell Count00%00%2022-05-25
2123MNvitGTA12RCCRelative Cell Count1540%00%2022-05-25
3123MNvitGTA13RPDRelative Population Doubling1540%00%2022-05-25
4123MNvitGTA14MNCELLSMicronucleated Cells220515Cells1515Cells2022-05-25
5123MNvitGTA15MNCELLSMicronucleated Cells247413Cells1313Cells2022-05-25
6123MNvitGTA16MNCELLSMicronucleated Cells275817Cells1717Cells2022-05-25
7123MNvitGTA17MNCELLSMicronucleated Cells266912Cells1212Cells2022-05-25
8123MNvitGTA18AVGRELAverage Relative MN Frequency
0.57%0.570.57%2022-05-25
9123MNvitGTA21RICCRelative Increase in Cell Count13415.7%15.715.7%2022-05-25
10123MNvitGTA22RCCRelative Cell Count13413.0%13.013.0%2022-05-25
11123MNvitGTA23RPDRelative Population Doubling1347.9%7.97.9%2022-05-25
12123MNvitGTA24MNCELLSMicronucleated Cells326620Cells2020Cells2022-05-25
13123MNvitGTA25MNCELLSMicronucleated Cells219017Cells1717Cells2022-05-25
14123MNvitGTA26MNCELLSMicronucleated Cells275813Cells1313Cells2022-05-25
15123MNvitGTA27MNCELLSMicronucleated Cells271421Cells2121Cells2022-05-25
16123MNvitGTA28AVGRELAverage Relative MN Frequency
0.66%0.660.66%2022-05-25
...